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Abstract 
Purpose: To develop a novel ultraviolet (UV)–spectrophotometric method for the determination of 
dihydroartemisinin (DHA) in tablets using p-nitroaniline (PNA) as a derivatizing agent. 
Methods: Derivatization was based on the reaction between methanol solutions of dihydroartemisinin 
(DHA) and p-nitroaniline (PNA) in acid medium (1M HCI) at elevated temperature and for a short 
reaction time. Optimal detector response was obtained within 15 min when the reaction was carried out 
at 90 0C in a molar ratio of 2:1 (DHA:PNA).  The method used for analysis was validated and a linear 
calibration curve constructed in the range of 30 – 100 µg/mL for the reaction mixture at an absorbance 
of 290 nm.  
Results: Separation of adduct from PNA was better achieved on reversed phase thin layer 
chromatography (TLC) using acetonitrile : water (60:50) or on high performance liquid chromatography 
(HPLC) with retention times of 2.8 min for PNA and 5.8 min for the adduct. The limit of detection was 6 
µg/mL. The method was precise and accurate in the range 100.70 - 100.96 %, with intraday and 
interday precisions of less than 2 % at concentrations of 40 and 80 µg/mL, respectively. The new 
method was applied to the assay of two brands of dihydroartemisinin tablets with accuracy similar to 
that of the International Pharmacopoeia (IP) UV-spectrophotometric method (p > 0.05).  
Conclusion: The derivatization method is simple, direct, devoid of dilutions and inexpensive in terms of 
reagent requirements and analyte volume, and has a shorter reaction time, cpmpared with IP method. 
Based on the foregoing, the method can be adopted as an alternative to the official assay method for 
routine quality control of dihydroartemisinin tablets.  
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Dihydroartemisinin is a semi-synthetic derivative 
and the major metabolite of the parent drug 
artemisinin (Qinghaosu) obtained from the plant 
Artemisia annua [1].  Owing to the increase in 
drug resistance, the World Health Organization 
(WHO) in 2005 recommended that all 
uncomplicated P. falciparum infections be treated 
with artemisinin-based combination therapies 
(ACTs) but DHA and the other artemisinin 
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derivatives lack chromophores, and therefore are 
UV-transparent and require derivatization 
procedures before UV-spectrophotometry can be 
applied [1]. 
 
Analytical procedures for the detection and assay 
of DHA and the other artemisinin-based drugs 
have been developed during the last 25 years 
but these either involve multiple dilution stages, 
long reaction hours or costly gadgets. In this 
paper, we report a novel UV-spectrophotometric 
method for the assay of Dihydroartemisinin 
Tablets using p-nitroaniline as the derivatizing 
agent. The new method is simple, direct, devoid 
of dilutions and inexpensive in reagents and 
analyte volumes and has a shorter reaction time 
with minimal instrumentation. The method 
compares well with the current International 
Pharmacopoeia IP (2003) method (p > 0.05). 
Consequently, we deem the method suitable for 
routine quality control analysis, especially routine 




Reagents and chemicals 
 
Methanol, ethyl acetate, chloroform, acetone, 
hydrochloric acid, p-nitroaniline, (BDH, UK), 
acetonitrile (Philips and Hams England), hexane 
(Hopkins and Williams, Birmingham, England), 
liquid paraffin, distilled water, Alaxin® 60 mg 
(dihydroartemisinin tablets, GVS Labs, India) and 
Cotecxin® 60 mg (dihydroartemisinin tablets, 




UV-visible spectrophotometer (Unicam Aurora, 
Helios Scan Software v 1.1, Pye Unicam, 
England), Buck Scientific Fourier transform 
infrared spectrophotometer model M500, HPLC 
(HP series 1100), Mettler analytical balance H80 





The derivatization reaction was based on the 
reaction between methanol solutions of 
dihydroartemisinin (DHA) and p-nitroaniline 
(PNA) in acid medium (1M HCI) at the elevated 
temperature of 90 oC. 
 
Stock solutions of DHA (100 µg/mL) and PNA 
(500 µg/mL) were prepared for the derivatization 
reaction. In order to determine the optimum 
conditions for the derivatization reaction, the 
following critical response parameters were 
optimized; (i) the strength of HCI required for the 
reaction (ii) stoichiometric ratio of drug – reagent 
(DHA-PNA) (iii) temperature of the reaction and 
(iv) reaction time 
 
Optimization of acid reaction condition 
 
Aliquot volumes (1 ml) each of 0.5, 1, 2, 3, 4 and 
5.0 M HCl were put into identical test-tubes with 
1 mL  of DHA stock solution (100 µg/mL) and 1 
mL PNA stock solution (500 µg/mL) added to 
each test tube and vortexed for 10 s. 1 mL of 
methanol in a similar test tube served as blank. 
The test tubes were incubated in a water bath at 
60 0C for 45 min. Again 1 mL each of DHA, PNA 
stock solutions and 0.2 mL 1M HCI were added 
in a test tube and vortexed for 10 s. The test tube 
was incubated in a water bath maintained at 60 
0C for 45 min. After cooling to room temperature 
(250C), 4 mL of methanol was added and the UV 
spectrum recorded on a UV-Visible 
spectrophotometer (Unicam Aurora, Helios Scan 
Software v 1.1, Pye Unicam, England) between 
190 - 800 nm. 
 
Determination of the stoichiometric ratio of 
drug – reagent (DHA-PNA)  
 
Equi-molar solutions (0.001M) of DHA (0.0284 g 
in 100 mL) and PNA (0.0138 g in 100 mL) were 
prepared in methanol. Into five different test 
tubes each containing 0.2 mL  of 1M HCl, 0.3, 
0.3, 0.3, 0.6 and 0.9 mL  respectively of DHA 
were added and vortexed for 10 seconds. 
Thereafter 0.3, 0.6, 0.9, 0.3, and 0.3 mL 
respectively of PNA were added and again 
vortexed for 10 seconds. Five test tubes serving 
as controls and each containing same 
constituents except for DHA (which was replaced 
with methanol) were also prepared. All ten test 
tubes were incubated in a water bath at 60 0C for 
45 min. The test tubes were left to cool at room 
temperature and 1 mL of methanol added. 0.5 
mL was withdrawn into a tube, diluted with 3 mL 
of methanol and absorbance determined at 290 
nm using a UV-visible spectrophotometer. 
 
Optimization of reaction temperature and 
time 
 
The temperature and time for optimum reaction 
were determined. Reaction mixtures containing 
0.6 mL of DHA (10-3M), 0.3 mL of PNA (10-4M), 
and 0.2 mL of 1M HCl were vortexed for 10 s and 
incubated at varying temperatures ranging from 
30 to 100 oC for 30 min. Methanol (1 mL) was 
added to each test tube to terminate the reaction 
and aliquots (0.5 mL) were withdrawn into 
sample tubes and again diluted to 3 mL with 
methanol and the absorbance of each sample 
tube was taken at 290 nm. Each reaction was 
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carried out in triplicate. The optimal reaction time 
followed the same procedure. Reaction tubes 
were incubated at 90 oC and reaction was 
terminated by adding 1 mL methanol at 5, 10, 15, 
30, 45 and 60 min, respectively. 0.5 mL of each 
test tube was withdrawn, diluted to 3 mL with 
methanol and absorbance reading taken at 290 
nm. The test was also carried out in triplicate. 
 
Determination of Rf values in different 
solvent systems 
 
The aim was to compare the Rf values of the 
DHA–PNA adduct and the reagent in various 
solvent systems and to confirm the evidence of a 
new adduct formation. To 1 mL DHA (100 
µg/mL), 0.2 mL 1M HCL and 0.1 mL PNA (500 
µg/mL) solutions were added in a tube and 
vortexed for 10 s. In a second tube 1 mL of 
methanol, 0.2 mL 1M HCL and 0.1 mL  PNA 
solution (500 µg/mL) were added and vortexed 
for 10 s. The two test tubes were then incubated 
at 90 0C for 15 min. The test tubes were cooled 
briefly and 3 mL of ethyl acetate and 3 mL of 
water were added and mixed again. From the 
ethyl acetate layer of each test tube about 5 μL 
was removed with capillary tube and spotted on 
silica gel plates separately. The following solvent 
systems were adopted during the investigation: 
 
Normal phase – (i) ethyl acetate: methanol (6:4) 
(ii) ethyl acetate: hexane (5:5) (iii) chloroform: 
toluene: acetone (65:25:10) (iv) chloroform: 
methanol (95:5) (v) methanol: strong ammonia 
(100:50), (vi) liquid paraffin: ether (5:5). 
 
 Reverse phase – Acetonitrile: water (60:40, 




The aim of the investigation was to confirm the 
formation of a new chemical entity by the 
reaction between p-nitroaniline and 
dihydroartemisinin. To 5 mL of 1 mg/mL DHA 
solution, 0.2 mL 1M HCI and 2.5 mL of 1 mg/mL 
PNA solution were added in five test tubes and 
vortexed for 10 s. The test tubes were incubated 
at 90 0C for 15 min and thereafter allowed to cool 
to room temperature. To each test tube, 3 mL of 
dichloromethane was added and mixed, and 
same volume of water was added and mixed 
again. The dichloromethane layers were carefully 
withdrawn into petri dishes, using a pipette, and 
allowed to dry in air. The powdery adduct was 
further dried in an oven at 50 0C and this powder 
along with the PNA powder were scanned on an 
IR spectrophotometer.  
 
Determination of Rt value in specified solvent 
system 
 
The aim of the investigation was to find a suitable 
column and solvent system that will separate the 
DHA-PNA adduct and p-nitroaniline (PNA). The 
adduct was prepared using 1 mL  DHA (100 
µg/mL) solution, 0.2 mL 1M HCl and 0.1 mL PNA 
(500 µg/mL) solution vortexed for 10 s and the 
reagent was made using 1 mL of methanol, 0.2 
mL 1M HCI and 0.1 mL PNA solution (500 
µg/mL)  vortexed for 10 s. Both tubes were 
incubated at 90 0C for 15 min, cooled to room 
temperature and 3 mL of ethyl acetate was 
added to each mixture, followed by addition of 3 
mL of water. From the ethyl acetate layer, 100 µL 
were removed into separate sample bottles, 
allowed to dry in air and then covered and stored 
at –20 0C prior to HPLC analysis. For HPLC 
analysis, each sample tube had 0.5 mL methanol 
added into it and 20 μL was injected into the 
column.  
 
Method validation  
 
At the optimal analytical conditions described 
above, the calibration lines were obtained using 
standard solutions of 30, 40, 50, 60, 80 and 100 
μg/mL. DHA. Linear regression analysis was 
used to calculate the slope, intercept and 
coefficient of determination (r2) of each 
calibration line. The limit of detection was 
computed from the calibration equation as the 
analyte concentration giving a signal equal to the 
blank signal plus three standard deviations of the 
blank [18]. The accuracy and precision of the 
method were determined as documented by the 
United States Pharmacopoeia (USP) [17]: 
Multiple analysis (n = 5) of DHA at two different 
known concentrations (40 and 80 μg/mL) were 
analysed daily (intra-day) and repeated for three 
days (inter-day) using the optimized analytical 
method. The results were computed as mean ± 
standard deviation for both intra-day and inter-
day analysis. Mean value within 15 % of the 
actual concentration value indicates the accuracy 
of the method and mean value within 15 % of the 
coefficient of variation ascertains the precision of 
the method. 
 
Assay of dosage form 
 
Two brands of DHA tablets, Cotecxin® (60mg) 
and Alaxin® (60mg) were used for the assay. An 
amount of powdered tablets (Alaxin®) equivalent 
to 10 mg of DHA was weighed and dissolved in 
10 mL of methanol. After 15 min, the suspension 
was filtered to remove the excipients and the 
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filtrate was labeled as the stock solution (1 
mg/mL).  A portion of this stock solution (2 mL) 
was measured into a 20 mL volumetric flask, 
diluted to volume with methanol to give a 100 
µg/mL working solution. Then 0.5 mL of the 
Alaxin® working solution was measured into four 
different test tubes and diluted to 1 mL with 
methanol to give a 50 µg/mL solution. To this, 
0.2 mL of 1M HCI was added and vortexed, 
followed by 0.1 mL of 500 µg/mL PNA solution 
and vortexed again. The tubes were incubated at 
900C for 15 minutes. The reaction was quenched 
with 3 mL of methanol and absorbance taken at 
290 nm. The assay procedure was repeated for 
Cotecxin® tablets and these two tablets were 
also assayed using IP (2003) method. Both 
methods were compared and a two–tailed 





Statistical analysis was carried out by Student t-
test (using Microsoft Excel 2007) when 
comparing the two assay methods with 




Stoichiometric ratio of drug – reagent (DHA-
PNA)  
 
The coupling reaction of dihydroartemisinin and 
p-nitroaniline solution was optimum at ratio 2:1 of 
drug to reagent (Figure 1) and formed an intense 











DHA:PNA Stoichiometric ratio  
Figure 1: Plot of absorbance against DHA:PNA 
stoichiometric ratio (1 = 1:1; 2 = 1:2; 3 = 1:3; 4 = 2:1; 5 
= 3:1 DHA:PNA respectively) 
 
Optimum reaction conditions, temperature 
and time 
 
The spectrum of the adduct indicated a 
hyperchromic shift with respect to that of the 
reagent with peaks at 205, 230 and 380 nm. The 
strength of HCI ideal for the reaction was 1M and 
the absorbance of the adduct was highest at 














Temp 0C/Time  (mins)  
Figure 2: Plot of absorbance against temperature (0C, 
♦) and time (min, ■) 
 
Chromatographic analysis showed that reversed 
phase systems gave a better separation of 
adduct from the reagent on both TLC and HPLC 
with acetonitrile:water ratios of 60:50, 40:50 and 
55:50 giving good separation. The IR spectrum 
of the dried adduct was different from that of the 
reagent, thus confirming the success of the 
derivatization reaction (Figure 3).  
 
Linear regression equation for the calibration line 
under optimal reaction conditions is  y = 0.0023x 
– 0.0018 with r2 of 0.9987. The limit of detection 
was 5.9 µg/mL. Validation studies show that the 
new method is precise and accurate. The 
intraday and interday precision was in the range 
1.13 – 1.52 % and 0.84 – 1.13 % respectively. 
The mean percentage accuracy of the method 
was in the range 100.79 – 100.96 %. 
 
Comparative analysis of the two brands of 
dihydroartemisinin by the official (IP 2003) and 
the new method is shown in Table 1. Using 
student t-test there is no significant difference 
between the official and the new method 
reported (p = 0.08).  
 
Table 1: Content (mean ± SD) of dihydroartemisinin 









Alaxin® 94.31± 2.12 95.47 ± 
0.67 
0.293779 






Figure 3 shows the IR spectrum of the reagent – 
PNA alone and when viewed simultaneously with 
the spectrum of the adduct, DHA-PNA. The 
adduct formed by the reaction of dihydro-
artemisinin with p-nitroaniline has an IR spectrum 
with prominent peaks in the fingerprint region 
(1500- 600 cm-1) that clearly differ from those of  
Babalola et al 





Figure 3: IR spectrum of PNA and DHA-PNA adduct viewed simultaneously 
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PNA - DHA adduct  
 
Figure 4: Proposed mechanism of reaction between DHA and PNA 
 
the reagent spectrum.  Notably, the UV 
absorption spectrum of adduct showed a 
hyperchromic shift relative to that of the reagent 
(not included). A possible mechanism of reaction 
for the adduct formation is, first, acid 
decomposition of DHA to form a product 
containing a carbonyl function which in turn 
reacts with the amine to generate an imine 
adduct. The presence of hyper-conjugation of 
bonds in the adduct thus formed accounts for the 
intense yellow color of the new compound 
(Figure 4). These considerations collectively 
suggest that the derivatization was successful 
and that a new chemical entity was formed. 
Indeed both the TLC and HPLC outcomes further 
confirm the formation of an adduct. 
 
Using Job’s method of continuous variation, a 
plot of absorbance against drug-reagent 
stoichiometric ratio showed maximum 
absorbance at a drug-reagent ratio of 2:1. While 
the possibility of multiple products can be 
suggested, TLC results did not indicate this. 
However, the HPLC separation on Hypersil 
column gave two separate peaks suggesting the 
formation of two main products. This 
corroborates the stoichiometric ratio 
determination. The optimum temperature and 
time for the reaction were 90 0C and 15 min, 
respwctively which compares with the reaction of 
artesunic acid with p-nitrobenzyl N, N 
diisopropylisourea at 80 0C for 2 h as reported by 
Zou et al [15] and others [16]. However, their 
reaction time of 2 h is much longer than the 15 
min recorded in this work. Also of importance is 
the 15 min reaction time in this experiment as 
against the IP method which requires at least 30 
min reaction time [2].  
 
A calibration curve constructed with our method 
at the absorbance at 290 nm, showed linearity in 
the range 30 - 100 µg/mL for DHA and 500 
µg/mL for PNA, with an r2 of 0.9987. The 
wavelength of 290 nm was selected because the 
two absorption maxima in the UV region (205 nm 
and 230 nm) were not suitable. Determination at 
205 nm is subject to error since it is less than the 
cut-off point of methanol (210 nm), and at 230 
nm, the peak is not visible at low concentrations 
of the drug and reagent. Our detection limit (6 
µg/mL) can be accounted for by the reduced 
reactivity of artemisinin moiety since it lacks 
reactive functional groups.  
Validation studies carried out on the new method 
showed that the proposed method is precise and 
accurate, thus making the method suitable for 
routine analysis of dihydroartemisinin tablets. 
The suitability of this new method for the analysis 
of dosage forms (tablets) was further quantified 
in the statistical comparison between it and the 
IP (2003) method for analysis of 
dihydroartemisinin tablets with a P-value = 0.08 , 
showing no significant difference, therefore 
implying their equivalence (Table 1). On the 
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whole, the proposed method offers the 
advantages over the current official method of a 
shorter reaction time, and also is more direct, 




A validated novel UV-spectrophotometric method 
has been developed for the assay of 
dihydroartemisinin tablets. The method is low-
cost, precise, accurate and simpler than the 
current official method. It is therefore 
recommended as an alternative method for 
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